Law enforcement seized almost 40 percent fewer cannabis plants in the U.S. in 2017 than the previous year, according to new numbers from the federal Drug Enforcement Administration (DEA). The annual data, published in the DEA’s Domestic Cannabis Eradication/Statistical Report, shows that the feds and their law enforcement partners seized about 3.38 million marijuana plants […]

In what is believed to be the first study of its kind, researchers at the University of Colorado, Denver will study the genes of those with a kind of epilepsy called Dravet Syndrome who have been treated with a strain of medical marijuana known as Charlotte’s Web. While anecdotal evidence suggests Charlotte’s Web can be […]

In an open-label observational trial at Primary Children’s hospital, 25 children and teens with treatment-resistant epilepsy who apply to be part of a new drug trial will, will receive Epidiolex, a liquid, purified form of cannabidiol (CBD), a non-psychoactive chemical in marijuana. The primary goal will be to test the tolerability of Epidiolex and the […]

Some families in North Carolina are applauding state lawmakers after passing a groundbreaking bill yesterday . Governor Pat McCrory says he plans to sign into law a bill that allows for medical use of cannabidiol oil for the treatment of seizures disorders, particularly those that seem to afflict children. Cannabidiol oil is derived from a […]

GW Pharmaceuticals, a bio-pharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its cannabinoid product platform, announced that the United States Food and Drug Administration (FDA) has granted their product, Epidiolex, Fast Track designation in the treatment of Dravet syndrome, a rare and catastrophic treatment-resistant form of childhood epilepsy. FDA’s Fast Track program facilitates the […]